Table 2.
Demographic and disease characteristics of women with breast cancer and women with no cancer (matched-controls)
| Characteristics | Women with breast cancer (n = 69) | Matched-controls (n = 64) |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 52.2 (9.5) | 51.9 (9.3) |
| Range | 31 – 80 | 29 – 81 |
| Body mass index (BMI, kg/m2) | ||
| Mean (SD) | 27.5 (7.4) | 26.9 (8.5) |
| Range | 19.3 – 61.9 | 19.1 – 64.5 |
| Race [n (%)] | ||
| Caucasian | 61 (88.4) | 56 (87.5) |
| Non-Caucasian | 8 (11.6) | 8 (12.5) |
| Education [n (%)] | ||
| Below competed college | 35 (50.7) | 23 (35.9) |
| Completed college and above | 34 (49.3) | 41 (64.1) |
| Marital status [n (%)] | ||
| Never married | 3 (4.3) | 7 (10.9) |
| Divorced/separated/widowed | 18 (26.1) | 13 (20.3) |
| Married | 48 (69.6) | 44 (68.8) |
| Household annual income [n (%)] | ||
| < $100,000 | 43 (62.3) | 41 (64.1) |
| > $100,000 | 26 (37.7) | 23 (35.9) |
| Baseline menopausal status [n (%)] | ||
| pre-menopause | 27 (40.9) | 23 (37.7) |
| peri-menopause | 7 (10.6) | 8 (13.1) |
| post-menopause | 27 (40.9) | 22 (36.1) |
| hysterectomy | 5 (7.6) | 8 (13.1) |
| Not available | 3 | 3 |
| Cancer stage [n (%)] | - | |
| Stage I | 16 (23.5) | |
| Stage II | 29 (42.7) | |
| Stage III | 23 (33.8) | |
| Not available | 1 | |
| Surgery type | - | |
| Lumpectomy | 33 (47.8) | |
| Mastectomy | 30 (43.5) | |
| Double mastectomy | 3 (4.3) | |
| No surgery before Chemotherapy | 3 (4.3) | |
| Chemotherapy regimen [n (%)] | - | |
| AC | 12 (18.2) | |
| AC + docetaxel | 6 (9.1) | |
| AC + paclitaxel | 34 (51.5) | |
| Other | 14 (21.2) | |
| Not available | 3 |
There were no significant differences between the two groups in age, BMI, race, education, marital status, household annual income, and baseline menopause status (all p’s > 0.09). AC Doxorubicin + Cyclophosphamide